These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 21121835)
21. Tobacco control and free speech--an American dilemma. Bayer R; Kelly M N Engl J Med; 2010 Jan; 362(4):281-3. PubMed ID: 20071696 [No Abstract] [Full Text] [Related]
22. Regulating Off-Label Promotion - A Critical Test. Robertson C; Kesselheim AS N Engl J Med; 2016 Dec; 375(24):2313-2315. PubMed ID: 27805841 [No Abstract] [Full Text] [Related]
23. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief. Chaps NA Issue Brief Health Policy Track Serv; 2010 Jan; ():1-31. PubMed ID: 20217914 [No Abstract] [Full Text] [Related]
24. Off-label marketing and the First Amendment. Boumil MM N Engl J Med; 2013 Jan; 368(2):103-5. PubMed ID: 23234470 [No Abstract] [Full Text] [Related]
25. Observations at the interface of mutation research and regulatory policy. Flamm WG Mutat Res; 2003 Sep; 544(1):1-7. PubMed ID: 12888105 [TBL] [Abstract][Full Text] [Related]
26. Food and drug regulation after 75 years. Hayes AH JAMA; 1981 Sep; 246(11):1223-6. PubMed ID: 7021890 [No Abstract] [Full Text] [Related]
27. Fifty years of drug amendments revisited: in easy-to-swallow capsule form. Kaplan AH Food Drug Law J; 1995; 50 Spec():179-96. PubMed ID: 10343042 [No Abstract] [Full Text] [Related]
28. Pharmaceuticals and medical devices: FDA oversight. ; Berry MD Issue Brief Health Policy Track Serv; 2012 Jan; ():1-86. PubMed ID: 22403845 [No Abstract] [Full Text] [Related]
29. Shattuck Lecture: improving American health. Freudenberg N N Engl J Med; 2007 Dec; 357(23):2405; author reply 2406-7. PubMed ID: 18057347 [No Abstract] [Full Text] [Related]
30. The short happy life of the first pharmacology division of the FDA: 1935-1936. Farrar GE Clin Ther; 1989; 11(1):183-4. PubMed ID: 2655903 [No Abstract] [Full Text] [Related]
31. Learning about the safety of drugs--a half-century of evolution. Avorn J N Engl J Med; 2011 Dec; 365(23):2151-3. PubMed ID: 22150034 [No Abstract] [Full Text] [Related]
32. Government tobacco regulation: opportunity for change. Myers ML Lancet; 2006 Jul; 368(9532):268-70. PubMed ID: 16860682 [No Abstract] [Full Text] [Related]
33. FDA regulation of tobacco. Nitzkin JL N Engl J Med; 2008 Nov; 359(19):2070; author reply 2070-1. PubMed ID: 18987378 [No Abstract] [Full Text] [Related]
34. The Evolution of Federal Regulation of Human Drugs in the United States: An Historical Essay. Hutt PB Am J Law Med; 2018 May; 44(2-3):403-451. PubMed ID: 30106657 [No Abstract] [Full Text] [Related]
35. The need for FDA regulation of tobacco products. Kennedy EM Yale J Health Policy Law Ethics; 2002; 3(1):101-8. PubMed ID: 12825428 [No Abstract] [Full Text] [Related]
36. Tobacco, public health, and the FDA. Curfman GD; Morrissey S; Drazen JM N Engl J Med; 2009 Jul; 361(4):402-3. PubMed ID: 19546344 [No Abstract] [Full Text] [Related]
37. Research opportunities concerning youth and the Family Smoking Prevention and Tobacco Control Act. DiFranza JR Nicotine Tob Res; 2012 Jan; 14(1):54-61. PubMed ID: 21975309 [No Abstract] [Full Text] [Related]
38. Trying times at the FDA--the challenge of ensuring the safety of imported pharmaceuticals. Schweitzer SO N Engl J Med; 2008 Apr; 358(17):1773-7. PubMed ID: 18434648 [No Abstract] [Full Text] [Related]
39. The FDA: is it protecting the public with one hand tied behind its back? Shedlin RS Law Med Health Care; 1992; 20(3):253-7. PubMed ID: 1434771 [No Abstract] [Full Text] [Related]
40. Measures to control tobacco use: immunity, advertising restrictions, and FDA control as proposed in the failed tobacco settlement. Pinto CF J Contemp Health Law Policy; 1998; 15(1):307-56. PubMed ID: 9989001 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]